The incidence of prostate cancer in a screening population with a serum prostate specific antigen between 2.5 and 4.0 ng./ml.: Relation to biopsy strategy

被引:91
作者
Babaian, RJ
Johnston, DA
Naccarato, W
Ayala, A
Bhadkamkar, VA
Fritsch, HA
机构
[1] Univ Texas, MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
[2] Univ Texas, MD Anderson Canc Ctr, Dept Biomath, Houston, TX 77030 USA
[3] Univ Texas, MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas, MD Anderson Canc Ctr, Dept Res Lab Med, Houston, TX 77030 USA
[5] Dade Behring Inc, Newark, DE USA
关键词
prostate-specific antigen; mass screening; incidence; biopsy;
D O I
10.1016/S0022-5347(05)66519-6
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Purpose: It has recently been suggested that the diagnostic threshold for the prostate specific antigen (PSA) assay be lowered to enhance prostate cancer detection. A 22% incidence of prostate cancer has been reported in men with PSA between 2.5 and 4.0 ng./ml. We designed a study to confirm this observation. Materials and Methods: Men who participated in our free early detection program and who had serum PSA between 2.5 and 4.0 ng./ml. were asked to undergo prostate biopsy. Of 268 eligible men 151 (56%) agreed to participate in this free trial. All men underwent biopsy using an 11-core multisite directed biopsy scheme. All biopsy cores were color coded for location specificity and examined by 1 pathologist. Results: Cancer was identified in 24.5% (37 of 151) of the men biopsied. The median age of men with cancer was 62 years (range 43 to 74). Conventional systematic sextant biopsies, which accounted for 6 of the 11 cores, detected 73.0% (27 of 37) of the cancers and the alternate site biopsies identified the remaining 10. Gleason score was 6 in 25 men, 3 + 4 in 5, 4 + 3 in 4 and 8 or greater in 3 (median Gleason score 6). There were 14 men who had 1 core positive for cancer, 9 had 2 and 14 had more than 2 (median number of positive cores 2). Of the 14 men with 1 positive core 11 had a less than 3 mm. focus of cancer and 8 had only a positive alternate site biopsy. There were 11 cases of abnormal results on digital rectal examination, 5 of which were cancer, and 31 cases of abnormal results on ultrasonography, 13 of which were cancer. Median biological variability in PSA was +/-15% (range 0.4% to 440.0%). Conclusions: We found a significant incidence of cancer (24.5%, 37 of 51) in men with serum PSA between 2.5 and 4.0 ng./ml. In our study 67.6% of the detected cancers were significant based on the biopsy data. If the PSA threshold is lowered the conventional systematic sextant technique may be preferable to an extended strategy.
引用
收藏
页码:757 / 760
页数:4
相关论文
共 18 条
  • [1] A comparative analysis of sextant and an extended 11-core multisite directed biopsy strategy
    Babaian, RJ
    Toi, A
    Kamoi, K
    Troncoso, P
    Sweet, J
    Evans, R
    Johnston, D
    Chen, M
    [J]. JOURNAL OF UROLOGY, 2000, 163 (01) : 152 - 157
  • [2] TUMOR VOLUME AND PROSTATE-SPECIFIC ANTIGEN - IMPLICATIONS FOR EARLY DETECTION AND DEFINING A WINDOW OF CURABILITY
    BABAIAN, RJ
    TRONCOSO, P
    STEELHAMMER, LC
    LLORETATRULL, J
    RAMIREZ, EI
    [J]. JOURNAL OF UROLOGY, 1995, 154 (05) : 1808 - 1812
  • [3] BABAIAN RJ, 1991, CANCER-AM CANCER SOC, V68, P2060
  • [4] Comparative analysis of prostate specific antigen and its indexes in the detection of prostate cancer
    Babaian, RJ
    Kojima, M
    Ramirez, EI
    Johnston, D
    [J]. JOURNAL OF UROLOGY, 1996, 156 (02) : 432 - 437
  • [5] PROSTATE SPECIFIC ANTIGEN DENSITY - A MEANS OF DISTINGUISHING BENIGN PROSTATIC HYPERTROPHY AND PROSTATE-CANCER
    BENSON, MC
    WHANG, IS
    PANTUCK, A
    RING, K
    KAPLAN, SA
    OLSSON, CA
    COONER, WH
    [J]. JOURNAL OF UROLOGY, 1992, 147 (03) : 815 - 816
  • [6] MEASUREMENT OF PROSTATE-SPECIFIC ANTIGEN IN SERUM AS A SCREENING-TEST FOR PROSTATE-CANCER
    CATALONA, WJ
    SMITH, DS
    RATLIFF, TL
    DODDS, KM
    COPLEN, DE
    YUAN, JJJ
    PETROS, JA
    ANDRIOLE, GL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) : 1156 - 1161
  • [7] Prostate cancer detection in men with serum PSA concentrations of 2.6 to 4.0 ng/mL and benign prostate examination - Enhancement of specificity with free PSA measurements
    Catalona, WJ
    Smith, DS
    Ornstein, DK
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (18): : 1452 - 1455
  • [8] KANE RA, 1992, CANCER-AM CANCER SOC, V69, P1201
  • [9] SERUM PROSTATE-SPECIFIC ANTIGEN IN A COMMUNITY-BASED POPULATION OF HEALTHY-MEN - ESTABLISHMENT OF AGE-SPECIFIC REFERENCE RANGES
    OESTERLING, JE
    JACOBSEN, SJ
    CHUTE, CG
    GUESS, HA
    GIRMAN, CJ
    PANSER, LA
    LIEBER, MM
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1993, 270 (07): : 860 - 864
  • [10] PARTIN AW, 1993, UROL CLIN N AM, V20, P713